INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 155 filers reported holding INARI MED INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,228,008 | +114.1% | 110,520 | +90.4% | 0.01% | +125.0% |
Q2 2023 | $3,375,608 | +1.6% | 58,060 | +7.9% | 0.00% | 0.0% |
Q1 2023 | $3,323,341 | +55.0% | 53,828 | +59.5% | 0.00% | +33.3% |
Q4 2022 | $2,144,451 | +13.5% | 33,739 | +32.1% | 0.00% | +50.0% |
Q3 2022 | $1,889,000 | -55.1% | 25,539 | -58.7% | 0.00% | -60.0% |
Q2 2022 | $4,206,000 | -15.5% | 61,863 | +12.7% | 0.01% | 0.0% |
Q1 2022 | $4,975,000 | +7.7% | 54,883 | +8.5% | 0.01% | +25.0% |
Q4 2021 | $4,619,000 | +111.2% | 50,603 | +87.7% | 0.00% | +100.0% |
Q3 2021 | $2,187,000 | +120.0% | 26,963 | +143.7% | 0.00% | +100.0% |
Q2 2021 | $994,000 | -16.0% | 11,065 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $1,184,000 | -6.2% | 11,065 | -23.5% | 0.00% | -50.0% |
Q4 2020 | $1,262,000 | +31.9% | 14,462 | +4.3% | 0.00% | +100.0% |
Q3 2020 | $957,000 | +42.6% | 13,862 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $671,000 | – | 13,862 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darsana Capital Partners LP | 1,426,584 | $115,696,000 | 3.81% |
Affinity Asset Advisors, LLC | 135,000 | $10,949,000 | 2.76% |
SECTORAL ASSET MANAGEMENT INC | 289,650 | $23,491,000 | 1.95% |
Pier Capital, LLC | 99,434 | $8,064,000 | 0.84% |
Beck Bode, LLC | 27,853 | $2,259,000 | 0.63% |
CNA FINANCIAL CORP | 22,993 | $1,865,000 | 0.51% |
NEXT CENTURY GROWTH INVESTORS LLC | 59,245 | $4,804,000 | 0.42% |
Birchview Capital, LP | 7,000 | $568,000 | 0.39% |
PDT Partners, LLC | 59,849 | $4,854,000 | 0.35% |
HAMILTON LANE ADVISORS LLC | 24,900 | $2,019,000 | 0.34% |